These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19042837)

  • 1. A pilot phase II randomized, cross-over, double-blinded, controlled efficacy study of octreotide versus hyoscine hydrobromide for control of noisy breathing at the end-of-life.
    Clark K; Currow DC; Agar M; Fazekas BS; Abernethy AP
    J Pain Palliat Care Pharmacother; 2008; 22(2):131-8. PubMed ID: 19042837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction.
    Mercadante S; Ripamonti C; Casuccio A; Zecca E; Groff L
    Support Care Cancer; 2000 May; 8(3):188-91. PubMed ID: 10789958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of glycopyrronium bromide and scopolamine hydrobromide in patients with death rattle: a randomized controlled study].
    Likar R; Rupacher E; Kager H; Molnar M; Pipam W; Sittl R
    Wien Klin Wochenschr; 2008; 120(21-22):679-83. PubMed ID: 19116709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Respiratory tract secretions in the dying patient: a comparison between glycopyrronium and hyoscine hydrobromide.
    Hugel H; Ellershaw J; Gambles M
    J Palliat Med; 2006 Apr; 9(2):279-84. PubMed ID: 16629557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of octreotide, scopolamine butylbromide, and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes: a prospective randomized trial.
    Ripamonti C; Mercadante S; Groff L; Zecca E; De Conno F; Casuccio A
    J Pain Symptom Manage; 2000 Jan; 19(1):23-34. PubMed ID: 10687323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized double-blind trial of sublingual atropine vs. placebo for the management of death rattle.
    Heisler M; Hamilton G; Abbott A; Chengalaram A; Koceja T; Gerkin R
    J Pain Symptom Manage; 2013 Jan; 45(1):14-22. PubMed ID: 22795904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atropine, hyoscine butylbromide, or scopolamine are equally effective for the treatment of death rattle in terminal care.
    Wildiers H; Dhaenekint C; Demeulenaere P; Clement PM; Desmet M; Van Nuffelen R; Gielen J; Van Droogenbroeck E; Geurs F; Lobelle JP; Menten J;
    J Pain Symptom Manage; 2009 Jul; 38(1):124-33. PubMed ID: 19361952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interventions for noisy breathing in patients near to death.
    Wee B; Hillier R
    Cochrane Database Syst Rev; 2008 Jan; 2008(1):CD005177. PubMed ID: 18254072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study comparing hyoscine hydrobromide and glycopyrrolate in the treatment of death rattle.
    Back IN; Jenkins K; Blower A; Beckhelling J
    Palliat Med; 2001 Jul; 15(4):329-36. PubMed ID: 12054150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of octreotide administration vs conservative treatment in the management of inoperable bowel obstruction in patients with far advanced cancer: a randomized, double- blind, controlled clinical trial.
    Mystakidou K; Tsilika E; Kalaidopoulou O; Chondros K; Georgaki S; Papadimitriou L
    Anticancer Res; 2002; 22(2B):1187-92. PubMed ID: 12168923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyoscine vs glycopyrronium for drying respiratory secretions in dying patients.
    Lawrey H
    Br J Community Nurs; 2005 Sep; 10(9):421-4, 426. PubMed ID: 16234752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisecretory agents in gastrointestinal obstruction.
    Muir JC; von Gunten CF
    Clin Geriatr Med; 2000 May; 16(2):327-34. PubMed ID: 10783431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial.
    Furey ML; Drevets WC
    Arch Gen Psychiatry; 2006 Oct; 63(10):1121-9. PubMed ID: 17015814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind, placebo-controlled, randomized trial of octreotide in malignant bowel obstruction.
    Currow DC; Quinn S; Agar M; Fazekas B; Hardy J; McCaffrey N; Eckermann S; Abernethy AP; Clark K
    J Pain Symptom Manage; 2015 May; 49(5):814-21. PubMed ID: 25462210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of the selective muscarinic M3 receptor antagonist darifenacin, and of hyoscine (scopolamine), on motion sickness, skin conductance & cognitive function.
    Golding JF; Wesnes KA; Leaker BR
    Br J Clin Pharmacol; 2018 Jul; 84(7):1535-1543. PubMed ID: 29522648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel consent process for research in dying patients unable to give consent.
    Rees E; Hardy J
    BMJ; 2003 Jul; 327(7408):198. PubMed ID: 12881261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of a selective muscarinic receptor antagonist and hyoscine (scopolamine) on motion sickness, skin conductance and heart rate.
    Golding JF; Stott JR
    Br J Clin Pharmacol; 1997 Jun; 43(6):633-7. PubMed ID: 9205824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scopolamine butylbromide plus octreotide in unresponsive bowel obstruction.
    Mercadante S
    J Pain Symptom Manage; 1998 Nov; 16(5):278-80. PubMed ID: 9846021
    [No Abstract]   [Full Text] [Related]  

  • 19. A retrospective analysis of primary diagnosis, comorbidities, anticholinergic load, and other factors on treatment for noisy respiratory secretions at the end of life.
    Sheehan C; Clark K; Lam L; Chye R
    J Palliat Med; 2011 Nov; 14(11):1211-6. PubMed ID: 21883008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Octreotide for the treatment of diarrhoea in patients with ileal pouch anal anastomosis: a placebo-controlled crossover study.
    Van Assche G; Ferrante M; Vermeire S; Noman M; Rans K; Van der Biest L; Penninckx F; Wolthuis A; Rutgeerts P; D'Hoore A
    Colorectal Dis; 2012 Apr; 14(4):e181-6. PubMed ID: 21951549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.